Square wave voltammetric determination of the angiotensin-converting enzyme inhibitors cilazapril, quinapril and ramipril in pharmaceutical formulations

Farmaco

Volumn 58, Issue 5, 2003, Pages 343-350

  Prieto, José Angel ^a   Jiménez, Rosa M ^a   Alonso, Rosa M ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Cilazapril; Pharmaceuticals; Quinapril; Ramipril; Square wave voltammetry

Indexed keywords

ACOVIL; ANTIHYPERTENSIVE AGENT; BICETIL; BUFFER; CARASEL; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ECTREN; ELECTROLYTE; HYDROCHLOROTHIAZIDE; INOCAR; POTASSIUM CHLORIDE; QUINAPRIL; RAMIPRIL;

ACCURACY; ARTICLE; CONCENTRATION (PARAMETERS); DRUG FORMULATION; ELECTRODE; PH; POTENTIOMETRY;

EID: 0037406052     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(03)00043-0     Document Type: Article

References (32)

1. Szucs T. Cilazapril: a review. Drugs. 41:1991;18-24.
2. Plosker G.L., Sorkin E.M. Quinapril. A further update of its pharmacology and therapeutic use in cardiovascular disorders. Drugs. 48:1994;227-252.
3. Todd P.A., Benfield P. Ramipril: a review of its pharmacological properties and therapeutic efficacy in cardiovascular disorders. Drugs. 39:1990;110-135.
4. Hardman J.G., Limburd L.E. The Pharmacological Basis of Therapeutics. 1996;McGraw-Hill, New York.
5. Piepho R.W. Overview of the angiotensin-converting enzyme inhibitors. Am. J. Health-Syst. Pharm. 57:2000;S3-S7.
6. Lever A.F., Hole D.J., Gillis C.R., McCallum I.R., McInnes G.T., MacKinnon P.L., Meredith P.A., Murray L.S., Reid J.L., Robertson J.W.K. Do inhibitors of angiotensin-I-converting enzyme protect against cancer? Lancet. 352:1998;179-184.
7. Waugh W.J. Factors to consider in selecting an angiotensin-converting enzyme inhibitor. Am. J. Health-Syst. Pharm. 57:2000;S26-S30.
8. Reid J.L. From kinetics to dynamics: are there differences between ACE inhibitors? Eur. Heart J. 18:1997;E14-E18.
9. Erk N., Onur F. Simultaneous determination of cilazapril and hydrochlorothiazide in tablets by spectrophotometric methods. Anal. Let. 29:1996;1963-1974.
10. Erk N. Determination of active ingredients in the pharmaceutical formulations containing hydrochlorothiazide and its binary mixtures with benazepril hydrochloride, triamterene and cilazapril by ration spectra derivative spectrophotometry and Vierordt's method. J. Pharm. Biomed. Anal. 20:1999;155-167.
11. Blaih S.M., Abdine H.H., El-Yazbi F.A., Shaalan R.A. Spectrophotometric determination of enalapril maleate and ramipril in dosage forms. Spectrosc. Let. 33:2000;91-102.
12. Abdellatef H.E., Ayad M.M., Taha E.A. Spectrophotometric and atomic absorption spectrometric determination of ramipril and perindopril through ternary complex formation with eosin and Cu(II). J. Pharm. Biomed. Anal. 18:1999;1021-1027.
13. Ayad M.M., Shalaby A.A., Abdellatef H.E., Hosny M.M. Spectrophotometric and AAS determination of ramipril and enalapril through ternary complex formation. J. Pharm. Biomed. Anal. 28:2002;311-321.
14. Gumieniczek A., Przyborowski L. Determination of benazepril and cilazapril in pharmaceuticals by high performance liquid chromatography. J. Liq. Chromatogr. Relat. Technol. 20:1997;2135-2142.
15. Prieto J.A., Jiménez R.M., Alonso R.M. Quantitative determination of the angiotensin-converting enzyme inhibitor cilazapril and its active metabolite cilazaprilat in pharmaceuticals and urine by high-performance liquid chromatography with amperometric detection. J. Chromatogr. B. 714:1998;285-292.
16. Prieto J.A., Jiménez R.M., Alonso R.M. Determination of the antihypertensive drug cilazapril and its active metabolite cilazaprilat in pharmaceuticals and urine by solid-phase extraction and high-performance liquid chromatography with photometric detection. J. Chromatogr. B. 754:2001;23-34.
17. Gumieniczek A., Hopkala H. High-performance liquid chromatographic assay of quinapril in tablets. Pharmaceutica Acta Helvetiae. 73:1998;183-185.
18. Hogan B.L., Willians M., Idiculla A., Veysoglu T., Parente E. Development and validation of a liquid chromatographic method for the determination of the related substances of ramipril in Altace capsules. J. Pharm. Biomed. Anal. 23:2000;637-651.
19. Belal F., Al-Zaagi I.A., Gadkariem E.A., Abounassif M.A. A stability-indicating LC method for the simultaneous determination of ramipril and hydrochlorothiazide in dosage forms. J. Pharm. Biomed. Anal. 24:2001;335-342.
20. Bonazzi D., Gotti R., Andrisano V., Cavrini V. Analysis of ACE inhibitors in pharmaceutical dosage forms by derivative UV spectroscopy and liquid chromatography (HPLC). J. Pharm. Biomed. Anal. 16:1997;431-438.
21. Gotti R., Andrisano V., Cavrini V., Bertucci C., Furlanetto S. Analysis of ACE inhibitors by capillary electrophoresis using alkylsulfonic additives. J. Pharm. Biomed. Anal. 22:2000;423-431.
22. Prieto J.A., Akesolo U., Jiménez R.M., Alonso R.M. Capillary zone electrophoresis applied to the determination of the angiotensin-converting enzyme inhibitor cilazapril and its active metabolite in pharmaceutical formulations and urine. J. Chromatogr. A. 916:2001;279-288.
23. Prieto J.A., Alonso R.M., Jiménez R.M. Determination of the angiotensin-converting enzyme inhibitor quinapril and its metabolite quinaprilat in pharmaceuticals and urine by capillary zone electrophoresis and solid-phase extraction. Electrophoresis. 23:2002;102-109.
24. Aboul-Enein H.Y., Stefan R.I., van Staden J.F. Analysis of several angiotensin-converting enzyme inhibitors using potentiometric, enantioselective membrane electrodes. Anal. Let. 32:1999;623-632.
25. Stefan R.I., Aboul-Enein H.Y., Radu G.L. Biosensor for enantioselective analysis of S-cilazapril, S-trandolapril, and S-pentopril. Prep. Biochem. Biotech. 28:1998;305-312.
26. Stefan R.I., van Staden R.F., Aboul-Enein H.Y. A new construction for a potentiometric, enantioselective membrane electrode. Its utilization to the S-captopril assay. Electroanalysis. 11:1999;192-194.
27. Tamer U., Özçiçek N.P., Atay O., Yildiz A. Voltammetric determination of cilazapril in pharmaceutical formulations. J. Pharm. Biomed. Anal. 29:2002;43-50.
28. Al-Majed A.A., Belal F., Abadi A., Al-Obaid A.M. The voltammetric study and determination of ramipril in dosage forms and biological fluids. Farmaco. 55:2000;233-238.
29. Belal F., Al-Zaagi I.A., Abounassif M.A. Voltammetric determination of benazepril and ramipril in dosage forms and biological fluids through nitrosation. J. AOAC Int. 84:2001;1-8.
30. Kocijan A., Grahek R., Kocjan D., Zupančič-Kralj L. Effect of column temperature on the behaviour of some angiotensin-converting enzyme inhibitors during high-performance liquid chromatographic analysis. J. Chromatogr. B. 755:2001;229-235.
31. Hillaert S., van den Bossche W. Optimization of capillary electrophoretic separation of several inhibitors of the angiotensin-converting enzyme. J. Chromatogr. A. 895:2000;33-42.
32. Miller J.C., Miller J.N. Statistics for Analytical Chemistry. 1989;Ellis Horwood, London.